In the complex ecosystem of pharmaceutical research and manufacturing, specific chemical compounds often serve as linchpins, enabling the synthesis of life-saving drugs. CAS number 98475-07-1, scientifically known as Methyl 2-Bromomethyl-3-Nitrobenzoate, is one such compound. Its significance lies primarily in its indispensable role as a pharmaceutical intermediate, particularly in the production of the widely used immunomodulatory drug, Lenalidomide. As a manufacturer and supplier, we recognize the critical importance of this molecule and the need for reliable sourcing.

Methyl 2-Bromomethyl-3-Nitrobenzoate is a structurally distinct organic molecule characterized by its ester, nitro, and benzylic bromide functionalities. This unique combination makes it a highly reactive and versatile synthon. The benzylic bromide moiety, in particular, is an excellent leaving group, making it prone to nucleophilic substitution reactions. This reactivity is precisely what is harnessed in the multi-step synthesis of Lenalidomide, where it facilitates key bond formations required to construct the final drug molecule.

The Indispensable Link to Lenalidomide Synthesis

Lenalidomide (CAS: 191732-72-6) is a cornerstone treatment for various hematological malignancies, including multiple myeloma and certain types of myelodysplastic syndromes. Its efficacy has revolutionized patient outcomes, making its consistent and high-quality production a global priority. Methyl 2-Bromomethyl-3-Nitrobenzoate is not merely an ingredient; it is a foundational building block that dictates the success of earlier synthetic stages. The purity and quality of this intermediate directly influence the yield, purity, and ultimately the safety and efficacy of the final Lenalidomide API (Active Pharmaceutical Ingredient).

As a manufacturer, we ensure that our Methyl 2-Bromomethyl-3-Nitrobenzoate meets stringent quality standards, with an assay of ≥98.5%. This high purity level is critical to minimize side reactions and the formation of unwanted byproducts, which can be challenging and expensive to remove in later stages of API manufacturing. When procurement teams look to buy this intermediate, they are looking for reliability and consistency, which we strive to deliver with every batch.

Beyond Lenalidomide: Potential and Versatility

While its role in Lenalidomide synthesis is its most prominent application, the inherent reactivity of Methyl 2-Bromomethyl-3-Nitrobenzoate suggests broader potential in organic chemistry. Its functional groups allow for diverse transformations, making it a valuable compound for research and development in the creation of other novel pharmaceuticals, agrochemicals, or specialty chemicals. The electron-withdrawing nitro group and the reactive benzylic bromide offer synthetic chemists numerous strategic pathways for molecular design.

The Importance of Reliable Suppliers for CAS 98475-07-1

For any pharmaceutical company or contract research organization, securing a stable and dependable supply of CAS 98475-07-1 is crucial. Working with reputable manufacturers and suppliers who can provide not only the product but also comprehensive technical data and robust quality control is essential. We understand the demanding nature of the pharmaceutical supply chain and are committed to being a trusted partner. Our manufacturing processes, adherence to quality specifications, and ability to supply in various quantities make us an ideal choice for those seeking to buy Methyl 2-Bromomethyl-3-Nitrobenzoate.

In conclusion, CAS 98475-07-1, Methyl 2-Bromomethyl-3-Nitrobenzoate, is more than just a chemical compound; it is a vital component in the production of a critical drug. Its reliable supply and high quality are paramount for the pharmaceutical industry. We are dedicated to meeting this demand, ensuring that researchers and manufacturers have access to this essential intermediate to advance healthcare solutions.